Home/ Stocks/ HIND

Vyome Holdings, Inc. Common Stock

HIND XNAS

$2.16 +0.15 (+7.01%) ▲ 15-min delayed

Open

$2.10

High

$2.16

Low

$1.99

Volume

15.2K

Market Cap

$15.02M

About Vyome Holdings, Inc. Common Stock

Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 18 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$31.6K	$-985,521	$-0.15
FY 2025	$319.7K	$-10,477,713	$-4.86
Q3 2025	$34.6K	$-8,595,300	$-3.12
TTM	$1.34M	$-11,169,261	$-0.38

Related Market News

No specific coverage for HIND yet. Check out our latest market news or earnings calendar.

Get HIND Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Vyome Holdings, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.